Absolutely. They just need to regroup and the right thing. In my opinion, the Allay clinical trial is the only viable option for them.
They got lucky with the foot and knee clearance, they should capitalize on them in the US market.
ALLAY CAN BE A BIG HIT. Clinical trial was scheduled to be completed by October 31, 2018. I am assuming that it should have been done by now but there is no official update by the company.